Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics
- 1 May 2013
- journal article
- review article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 1 (3) , 251-261
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospectsCancer Treatment Reviews, 2012
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung CarcinomaCancer Cell, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerThe Lancet Oncology, 2008
- Circulating mutant DNA to assess tumor dynamicsNature Medicine, 2008
- Drivers and passengersNature, 2007
- A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenesCancer Cell, 2006